Product Images Losartan Potassium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Losartan Potassium NDC 53002-5624 by Rpk Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This appears to be a graph or chart of some sort, showing the adjusted risk reduction percentages for Atenolol and Losartan Potassium over a period of 66 study months. Due to the lack of additional information, it is not possible to provide more context or details about the study or its findings.*
This appears to be a table or a figure depicting primary endpoint events within different demographic subgroups, showing results for age, gender, race, and other factors. The specific details of the results cannot be determined due to the unclear text.*
This is a statistical representation of an event in a study evaluating the effectiveness of Losartan Potassium compared to a placebo. The text indicates that out of the patients involved, 60% had an event in the Losartan group, while 40% had an event in the placebo group. The risk reduction was found to be 16.1% with a p-value of 0.022.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.